Bristol-Myers Squibb (BMY) advances ImClone Systems Inc. (IMCL) Partnership, Proposes Acquisition, Article Posted on BeaconEquity.com
The first six months of the year bustled with exciting news all over life sciences, with large pharmaceuticals getting into biotech buying spree of sorts. Biotechs are enjoying the courtship of drug developers looking to fuel their own dwindling pipeline
(EMAILWIRE.COM, July 31, 2008 ) DALLAS, Texas - BeaconEquity.com announces the publication of ‘Bristol-Myers Squibb (BMY) advances ImClone Systems Inc. (IMCL) Partnership, Proposes Acquisition’
Investors can view all of the investment articles for free by visiting:
http://www.beaconequity.com/m - Click on News and Commentary
Bristol-Myers Squibb (BMY) advances ImClone Systems Inc. (IMCL) Partnership, Proposes Acquisition
”The first six months of the year bustled with exciting news all over life sciences, with large pharmaceuticals getting into biotech buying spree of sorts. Biotechs are enjoying the courtship of drug developers looking to fuel their own dwindling pipelines and investors with less tolerance for risk. Research studies suggest that biotechnology firms achieve a significant increase in market value after completing several partnership deals with pharmaceutical companies, emphasizing the rising importance of pharma-biotech alliances…
“Stirring a new interest in pharmaceutical-biotech alliances front, New York-based pharmaceuticals manufacturer Bristol-Myers today proposed to acquire ImClone Systems, a biopharmaceutical company dedicated to developing biologic medicines in the area of oncology…
“Commenting on the proposed takeover, Bristol-Myers Squibb's chairman and CEO James M. Cornelius said the company's proposed acquisition of ImClone represents an evolutionary development in their companies’ seven-year-long relationship, and is in the best interests of Bristol-Myers Squibb and ImClone shareholders and employees and the patients they serve together…”
To read the entire article visit http://www.beaconequity.com/m – Click on News and Commentary
Join the fastest growing investor community at:
http://www.stockhideout.com
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.beaconequity.com/m
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/m
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
Investors can view all of the investment articles for free by visiting:
http://www.beaconequity.com/m - Click on News and Commentary
Bristol-Myers Squibb (BMY) advances ImClone Systems Inc. (IMCL) Partnership, Proposes Acquisition
”The first six months of the year bustled with exciting news all over life sciences, with large pharmaceuticals getting into biotech buying spree of sorts. Biotechs are enjoying the courtship of drug developers looking to fuel their own dwindling pipelines and investors with less tolerance for risk. Research studies suggest that biotechnology firms achieve a significant increase in market value after completing several partnership deals with pharmaceutical companies, emphasizing the rising importance of pharma-biotech alliances…
“Stirring a new interest in pharmaceutical-biotech alliances front, New York-based pharmaceuticals manufacturer Bristol-Myers today proposed to acquire ImClone Systems, a biopharmaceutical company dedicated to developing biologic medicines in the area of oncology…
“Commenting on the proposed takeover, Bristol-Myers Squibb's chairman and CEO James M. Cornelius said the company's proposed acquisition of ImClone represents an evolutionary development in their companies’ seven-year-long relationship, and is in the best interests of Bristol-Myers Squibb and ImClone shareholders and employees and the patients they serve together…”
To read the entire article visit http://www.beaconequity.com/m – Click on News and Commentary
Join the fastest growing investor community at:
http://www.stockhideout.com
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.beaconequity.com/m
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/m
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
Press Release Keywords:
stock market, investing, investment ideas, market activity, small caps, micro caps, beaconequity.com, bristol-myers squibb, imclone systems, blue chips, marketing solutions, search engines, pharmaceutical stocks
stock market, investing, investment ideas, market activity, small caps, micro caps, beaconequity.com, bristol-myers squibb, imclone systems, blue chips, marketing solutions, search engines, pharmaceutical stocks
|
How to buy Penny Stocks
Learn the Skills, Make the Trades, Earn a Fortune! 100% Free to try. Chartpoppers.com Stop Being Fooled By "Penny Stock Picks" Subscribe To The #1 Rated MicroCap Stock Newsletter. MicroCapster.com Analyst Penny Stock Picks Visit StockSource.us for explosive stock picks, free stock research and trading tools www.StockSource.us Your text Ads here! Ads are only $575 per month. Ads are placed same day. Contac Us Emailwire.com/contact.php |